Cel-Sci
CVM
#9791
Rank
C$66.39 M
Marketcap
C$7.90
Share price
-1.19%
Change (1 day)
-54.15%
Change (1 year)

Cel-Sci (CVM) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$16.6 Million

According to Cel-Sci 's latest financial reports the company's total liabilities are C$16.6 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cel-Sci - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-09-30C$16.98 M-11.11%
2024-09-30C$19.1 M-18.8%
2023-09-30C$23.52 M-6.99%
2022-09-30C$25.29 M3.15%
2021-09-30C$24.52 M-11.42%
2020-09-30C$27.68 M-7.03%
2019-09-30C$29.78 M-21.61%
2018-09-30C$37.98 M16.62%
2017-09-30C$32.57 M-3.19%
2016-09-30C$33.65 M-24.15%
2015-09-30C$44.36 M350.58%
2014-09-30C$9.84 M130.47%
2013-09-30C$4.27 M-51.98%
2012-09-30C$8.89 M-10.09%
2011-09-30C$9.89 M-3.53%
2010-09-30C$10.25 M-74.56%
2009-09-30C$40.32 M885.76%
2008-09-30C$4.09 M-31.95%
2007-09-30C$6.01 M-49.14%
2006-09-30C$11.81 M921.98%
2005-09-30C$1.15 M-34.08%
2004-09-30C$1.75 M-22.83%
2003-09-30C$2.27 M-46.83%
2002-09-30C$4.27 M433.26%
2001-09-30C$0.8 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
C$154.56 B 930,646.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$109.61 B 659,986.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C$0.33 B 1,896.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
C$57.62 M 247.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$44.38 B 267,157.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
C$1.13 B 6,739.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$1.19 B 7,101.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C$3.54 M-78.67%๐Ÿ‡บ๐Ÿ‡ธ USA